Lupin LimitedNSE: LUPIN

Press Release Jul 21 2023

· Issued by Lupin Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jul-21-2023-3

Lupin Limited has informed the Exchange regarding a press release dated July 21, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets".

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases